Cancer Registry Software Market Development, Industry Trends and Future Prospective to 2023
Global Cancer Registry Software Market Research Report By Type (Integrated Software, Standalone Software), Deployment Model (Cloud-Based, On-Premise), Database Type (Commercial, Public), Functionality (Patient Care Management, Product Outcome Evaluation, Cancer Reporting to Meet State, Federal Regulations, Medical Research and Clinical Studies), End User (Hospitals, Medical Practices, Government Organizations, Research Centers, Pharmaceutical, Biotechnology, Medical Device Companies and Others) - Forecast till 2024
Market Scenario
The global cancer registry software market is expected to grow significantly over the forecast period. The market held a market value of USD 56.4 million in 2018 and is projected to grow at a CAGR of 10.7% over the forecast period.
Increasing prevalence of cancer, favorable government initiatives, rising pressure to improve the quality of care and reduce healthcare costs, rising adoption of EHRs, and the growing use of cancer patient registry data for post-marketing surveillance are positively affecting market growth.
Request for Free Sample@ https://www.marketresearchfuture.com/sample_request/7852
Regional Analysis
On a regional basis, the Americas is anticipated to dominate the global cancer registry software market owing to the innovative product development and increasing investment in research and development for innovation in the region.
Europe is expected to hold the second largest position in the global cancer registry software market owing to the presence of strong academic & research base and availability of funding for research in the European countries.
Asia-Pacific is anticipated to be the fastest growing region in the global cancer registry software market owing to the shift of pharmaceutical companies to countries such as India and China, which are low-cost manufacturing regions.
The Middle East & Africa has the least share of the global cancer registry software market. Moreover, the major market share of the region is expected to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.
Segmentation
The global cancer registry software market has been segmented into type, deployment model, database type, functionality and end user.
By type, the market has been segmented into integrated software and standalone software.
Based on deployment model, the market has been segmented into cloud-based models and on-premise models.
On the basis of database type, the market has been segmented into commercial databases and public databases.
By functionality, the market has been segmented into patient care management, product outcome evaluation, cancer reporting to meet state and federal regulations, medical research & clinical studies.
The market, by end user, has been segmented into hospitals & medical practices, government organizations & research centers, pharmaceutical, biotechnology, and medical device companies, and others.
Browse Complete Report @ https://www.marketresearchfuture.com/reports/cancer-registry-software-market-7852
Key Players
Some of the prominent players in the global cancer registry software market are Onco, Inc., Rocky Mountain Cancer Data Systems, McKesson Corporation, Elekta AB (PUB), C/Net Solutions, Electronic Registry Systems, Inc., Rocky Mountain Cancer Data Systems, McKesson Corporation, Ordinal Data Inc, Conduent Inc, IBM, Himagine Solutions Inc.
Comments
Post a Comment